Drugs / human glucocerebrosidase cDNA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00001234 | Jan 1988 → Apr 2002 | Gaucher disease | National Institute of Neurological Disorders and Stroke (NINDS) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | human glucocerebrosidase cDNA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00001234 ↗ |
| Action | Restore | “This study is designed to measure the safety and effectiveness of transferring working copies of genes responsible for making missing enzymes into the cells of patients with...” NCT00001234 ↗ |